Drug discovery research

Test to detect early Parkinson's given FDA Breakthrough Device Designation


The biotech company Amprion have developed a test to detect the early signs of Parkinson's, before the onset of symptoms, which they hope will be ready to market in the next 18 months.

Read more about <span property="schema:name" class="field field--name-title field--type-string field--label-hidden">Test to detect early Parkinson&#039;s given FDA Breakthrough Device Designation</span>